Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06419335 · ClinicalTrials.gov registry record · Early Phase 1
Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study
A Early Phase 1 study, sponsored by University of Pennsylvania.
- Active
- Registry status
- Early Phase 1
- Development phase
- 60
- Enrollment target
NCT06419335: Active Early Phase 1 study, sponsored by University of Pennsylvania.
NCT06419335 is a Early Phase 1 study that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06419335, a Early Phase 1 study, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study includes an open label clinical trial comparing two doses of CoQ10 for 8 weeks to improve fatigue among patients with Crohn's disease and a prospective cohort study of healthy controls taking CoQ10 for 2 weeks. Additionally, among 15 participants who do not meet the fatigue threshold for the open label trial, the investigators will measure CoQ10 levels in blood and fasting urine, as well as complete the same data collection. Hypotheses 1. Fatigue will improve with CoQ10 and there will be a dose response with greater improvement with higher dose as measured by the Patient Reported Outcomes Measurement Information Systems Fatigue PROMIS Fatigue 7a instrument. 2. Fatigue will improve when measured with other fatigue scales in a similar dose dependent manner and that general and physical fatigue will improve more than mental fatigue. 3. CoQ10 will improve quality of life as measured with the short Inflammatory Bowel Disease Questionnaire (sIBDQ).
Interventions
- DRUG CoQ10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-07-20 |
| Est. Completion | 2026-09-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06419335
The ClinicalTrials.gov registry entry for NCT06419335 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CoQ10 is the first listed.
NCT06419335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06419335 about?
NCT06419335 is a clinical study titled "Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study". This study includes an open label clinical trial comparing two doses of CoQ10 for 8 weeks to improve fatigue among patients with Crohn's disease and a prospective cohort study of healthy controls taking CoQ10 for 2 weeks. Additionally, among 15 participants who do not meet the fatigue threshold for ...
What is the current status of trial NCT06419335?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 60 participants. The study started on 2024-07-20. Estimated completion is 2026-09-01.
What interventions are being tested in trial NCT06419335?
The interventions under investigation include: CoQ10 (DRUG).
Who is sponsoring clinical trial NCT06419335?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.